High accumulation of arsenic in the esophagus of mice after exposure to arsenite

Archives of Toxicology

Volumn 89, Issue 10, 2015, Pages 1751-1758

  Sumi, Daigo ^a   Tsurumoto, Miyu ^a   Yoshino, Yuri ^a   Inoue, Masahisa ^a   Yokobori, Takehiko ^b   Kuwano, Hiroyuki ^b   Himeno, Seiichiro ^a  

^a TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

Aquaglyceroporin; Arsenic; Esophagus; Glutathione; Multidrug resistance protein; Nrf2

Indexed keywords

AQUAGLYCEROPORIN; AQUAGLYCEROPORIN 3; AQUAGLYCEROPORIN 7; AQUAGLYCEROPORIN 9; ARSENITE SODIUM; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; MESSENGER RNA; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; AQP3 PROTEIN, MOUSE; AQUAPORIN 3; ARSENOUS ACID DERIVATIVE; NFE2L2 PROTEIN, MOUSE; P-GLYCOPROTEIN 2; SODIUM DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ESOPHAGUS LEVEL; DRUG EXPOSURE; DRUG TISSUE LEVEL; ESOPHAGUS; GLUTATHIONE METABOLISM; HEART; KIDNEY; LIVER; LUNG; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; C57BL MOUSE; DOSE RESPONSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM; TIME FACTOR; TISSUE DISTRIBUTION;

ANIMALS; AQUAPORIN 3; ARSENITES; DOSE-RESPONSE RELATIONSHIP, DRUG; ESOPHAGUS; GENE EXPRESSION REGULATION; GLUTATHIONE; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MICE, INBRED C57BL; NF-E2-RELATED FACTOR 2; P-GLYCOPROTEINS; RNA, MESSENGER; SODIUM COMPOUNDS; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 84942197073     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-014-1326-3     Document Type: Article

References (35)

1. Aono J, Yanagawa T, Itoh K et al (2003) Activation of Nrf2 and accumulation of ubiquitinated A170 by arsenic in osteoblasts. Biochem Biophys Res Commun 305(2):271–277
2. Aposhian HV, Aposhian MM (2006) Arsenic toxicology: five questions. Chem Res Toxicol 19(1):1–15
3. Bertolero F, Marafante E, Rade JE, Pietra R, Sabbioni E (1981) Biotransformation and intracellular binding of arsenic in tissues of rabbits after intraperitoneal administration of 74As labelled arsenite. Toxicology 20(1):35–44
4. Chen CJ, Hsueh YM, Lai MS et al (1995) Increased prevalence of hypertension and long-term arsenic exposure. Hypertension 25(1):53–60
5. Crecelius EA (1977) Changes in the chemical speciation of arsenic following ingestion by man. Environ Health Perspect 19:147–150
6. Hayakawa T, Kobayashi Y, Cui X, Hirano S (2005) A new metabolic pathway of arsenite: arsenic–glutathione complexes are substrates for human arsenic methyltransferase Cyt19. Arch Toxicol 79(4):183–191
7. Healy SM, Wildfang E, Zakharyan RA, Aposhian HV (1999) Diversity of inorganic arsenite biotransformation. Biol Trace Elem Res 68(3):249–266
8. IARC monographs on the evaluation of carcinogenic risks to humans (2012) Arsenic and Arsenic compounds. Arsenic, metals, fibres, and dusts: a review of human carcinogens, vol 100C, pp 41–85
9. Ishibashi K, Sasaki S, Fushimi K et al (1994) Molecular cloning and expression of a member of the aquaporin family with permeability to glycerol and urea in addition to water expressed at the basolateral membrane of kidney collecting duct cells. Proc Natl Acad Sci U S A 91(14):6269–6273
10. Itoh K, Chiba T, Takahashi S et al (1997) An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun 236(2):313–322
11. Itoh K, Tong KI, Yamamoto M (2004) Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles. Free Radic Biol Med 36(10):1208–1213
12. Kadono T, Inaoka T, Murayama N et al (2002) Skin manifestations of arsenicosis in two villages in Bangladesh. Int J Dermatol 41(12):841–846
13. Kala SV, Neely MW, Kala G et al (2000) The MRP2/cMOAT transporter and arsenic-glutathione complex formation are required for biliary excretion of arsenic. J Biol Chem 275(43):33404–33408
14. Kimura A, Ishida Y, Wada T, Yokoyama H, Mukaida N, Kondo T (2005) MRP-1 expression levels determine strain-specific susceptibility to sodium arsenic-induced renal injury between C57BL/6 and BALB/c mice. Toxicol Appl Pharmacol 203(1):53–61
15. Kobayashi M, Li L, Iwamoto N et al (2009) The antioxidant defense system Keap1-Nrf2 comprises a multiple sensing mechanism for responding to a wide range of chemical compounds. Mol Cell Biol 29(2):493–502
16. Koyama Y, Yamamoto T, Tani T et al (1999) Expression and localization of aquaporins in rat gastrointestinal tract. Am J Physiol 276(3 Pt 1):C621–C627
17. Kumagai Y, Sumi D (2007) Arsenic: signal transduction, transcription factor, and biotransformation involved in cellular response and toxicity. Annu Rev Pharmacol Toxicol 47:243–262
18. Lee TC, Ho IC, Lu WJ, Huang JD (2006) Enhanced expression of multidrug resistance-associated protein 2 and reduced expression of aquaglyceroporin 3 in an arsenic-resistant human cell line. J Biol Chem 281(27):18401–18407
19. Leslie EM (2012) Arsenic-glutathione conjugate transport by the human multidrug resistance proteins (MRPs/ABCCs). J Inorg Biochem 108:141–149
20. Leslie EM, Haimeur A, Waalkes MP (2004) Arsenic transport by the human multidrug resistance protein 1 (MRP1/ABCC1). Evidence that a tri-glutathione conjugate is required. J Biol Chem 279(31):32700–32708
21. Lin S, Shi Q, Nix FB et al (2002) A novel S-adenosyl-l-methionine: arsenic(III) methyltransferase from rat liver cytosol. J Biol Chem 277(13):10795–10803
22. Liu Z, Shen J, Carbrey JM, Mukhopadhyay R, Agre P, Rosen BP (2002) Arsenite transport by mammalian aquaglyceroporins AQP7 and AQP9. Proc Natl Acad Sci U S A 99(9):6053–6058
23. Liu Z, Carbrey JM, Agre P, Rosen BP (2004) Arsenic trioxide uptake by human and rat aquaglyceroporins. Biochem Biophys Res Commun 316(4):1178–1185
24. Lorico A, Bertola A, Baum C, Fodstad O, Rappa G (2002) Role of the multidrug resistance protein 1 in protection from heavy metal oxyanions: investigations in vitro and in MRP1-deficient mice. Biochem Biophys Res Commun 291(3):617–622
25. Ma T, Frigeri A, Hasegawa H, Verkman AS (1994) Cloning of a water channel homolog expressed in brain meningeal cells and kidney collecting duct that functions as a stilbene-sensitive glycerol transporter. J Biol Chem 269(34):21845–21849
26. Ma T, Song Y, Yang B et al (2000) Nephrogenic diabetes insipidus in mice lacking aquaporin-3 water channels. Proc Natl Acad Sci U S A 97(8):4386–4391
27. McMahon M, Itoh K, Yamamoto M et al (2001) The Cap’n’Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. Cancer Res 61(8):3299–3307
28. McWalter GK, Higgins LG, McLellan LI et al (2004) Transcription factor Nrf2 is essential for induction of NAD(P)H:quinone oxidoreductase 1, glutathione S-transferases, and glutamate cysteine ligase by broccoli seeds and isothiocyanates. J Nutr 134(12 Suppl):3499S–3506S
29. Pi J, Qu W, Reece JM, Kumagai Y, Waalkes MP (2003) Transcription factor Nrf2 activation by inorganic arsenic in cultured keratinocytes: involvement of hydrogen peroxide. Exp Cell Res 290(2):234–245
30. Stevens JT, Hall LL, Farmer JD, DiPasquale LC, Chernoff N, Durham WF (1977) Disposition of 14C and/or 74As-cacodylic acid in rats after intravenous, intratracheal, or peroral administration. Environ Health Perspect 19:151–157
31. Vahter M, Marafante E, Lindgren A, Dencker L (1982) Tissue distribution and subcellular binding of arsenic in marmoset monkeys after injection of 74As-arsenite. Arch Toxicol 51:65–72
32. Waalkes MP, Fox DA, States JC, Patierno SR, McCabe MJ Jr (2000) Metals and disorders of cell accumulation: modulation of apoptosis and cell proliferation. Toxicol Sci 56(2):255–261
33. Wang XJ, Sun Z, Chen W, Eblin KE, Gandolfi JA, Zhang DD (2007) Nrf2 protects human bladder urothelial cells from arsenite and monomethylarsonous acid toxicity. Toxicol Appl Pharmacol 225(2):206–213
34. Waters SB, Devesa V, Del Razo LM, Styblo M, Thomas DJ (2004) Endogenous reductants support the catalytic function of recombinant rat cyt19, an arsenic methyltransferase. Chem Res Toxicol 17(3):404–409
35. Wysocki R, Chery CC, Wawrzycka D et al (2001) The glycerol channel Fps1p mediates the uptake of arsenite and antimonite in Saccharomyces cerevisiae. Mol Microbiol 40(6):1391–1401